New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Annexon, Inc.
ANNX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

782M

Biotechnology

Next Earning date - 11 Nov 2024

782M

Biotechnology

Next Earning date - 11 Nov 2024

7.40USD
Shape-0.04 ( -0.54%)
favorite-chart

Relative Strenght

80
favorite-chart

Volume Buzz

-56%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

12%

Quote Panel

Shape
Updated October 26, 2024
1W -1.07 % 1M 20.52 % 3M 14.55 % 1Y 255.77 %

Key Metrics

Shape
  • Market Cap

    781.84M


  • Shares Outstanding

    105.65M


  • Share in Float

    83.99M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    7.4


  • Average Volume

    1.22M


  • Beta

    1.279


  • Range

    2.045-8.4


  • Industry

    Biotechnology


  • Website

    https://www.annexonbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

160.67x

P/S Ratio

2.67x

P/B Ratio

0.1

Debt/Equity

-2366.6%

Net Margin

$-1.2

EPS

How ANNX compares to sector?

P/E Ratio

Relative Strength

Shape

ANNX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11M

ShapeNaN%

2025-Revenue

$1.14

Shape-395%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bank of America Securities

upgrade

Previous: Not converted

2023-12-21

Now: Buy

Jefferies

initialise

Previous: Not converted

2022-09-16

Now: Buy

H.C. Wainwright

initialise

Previous: Not converted

2021-11-30

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.51
vs -0.93

Q4.22

arrow
arrow

N/A

-0.48
vs -0.97

Q1.23

arrow
arrow

N/A

-0.52
vs -0.92

Q2.23

arrow
arrow

N/A

-0.47
vs -0.96

Q3.23

arrow
arrow

N/A

-0.43
vs -0.51

Q4.23

arrow
arrow

N/A

-0.36
vs -0.48

Q1.24

arrow
arrow

N/A

-0.21
vs -0.52

Q2.24

arrow
arrow

N/A

-0.23
vs -0.47

Q3.24

arrow
arrow

N/A

-0.26
vs -0.43

Q4.24

arrow
arrow

N/A

-0.28
vs -0.36

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

4.9M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-13%

-0.13
vs -0.22

Q4.22

arrow
arrow

-14%

-0.14
vs -0.13

Q1.23

arrow
arrow

-17%

-0.17
vs -0.14

Q2.23

arrow
arrow

-19%

-0.19
vs -0.17

Q3.23

arrow
arrow

-21%

-0.21
vs -0.19

Q4.23

arrow
arrow

-11%

-0.11
vs -0.21

Q1.24

arrow
arrow

-10%

-0.10
vs -0.11

Q2.24

arrow
arrow

-8%

-0.08
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

76

76
vs 81

-6%

Q4.22

arrow
arrow

90

90
vs 76

18%

Q1.23

arrow
arrow

103

103
vs 90

14%

Q2.23

arrow
arrow

100

100
vs 103

-3%

Q3.23

arrow
arrow

97

97
vs 100

-3%

Q4.23

arrow
arrow

102

102
vs 97

5%

Q1.24

arrow
arrow

135

135
vs 102

32%

Q2.24

arrow
arrow

157

157
vs 135

16%

Earnings Growth

Latest News